Home » Basilea’s Toctino Recommended for Approval in 15 Additional European Countries
Basilea’s Toctino Recommended for Approval in 15 Additional European Countries
Basilea Pharmaceutica Ltd. announces that Toctino
(alitretinoin) was recommended for regulatory approval under the Repeat-use Procedure in 13 additional European Union Member States as well as in Norway
and Iceland.
CNNMoney
CNNMoney
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May